Fresenius reported EUR7.86B in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Akzo Nobel AKZA:NA EUR 1.68B 209M
Alcon AG ALC:SW USD 998M 26M
AstraZeneca AZN:LN USD 2.51B 393M
BASF BAS:GR EUR 14.98B 2.08B
Bayer BAYN:GR EUR 4.77B 521M
Davita Healthcare Partners DVA:US USD 2.09B 3.13M
E.ON EOAN:GR EUR 6.57B 31.96B
Essilor EI:FP EUR 4.74B 355M
Fresenius FRE:GR EUR 7.86B 105M
Fresenius Medical Care FME:GR EUR 3.65B 88.3M
Fresenius Medical Care FMS:US EUR 3.65B 88.3M
Getinge GETIB:SS SEK 4.67B 1.11B
Givaudan GIVN:VX CHF 2.16B 31M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
GN Store Nord GN:DC DKK 2.73B 380M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Lonza Group LONN:SW CHF 2B 213M
Merck MRK:GR EUR 2.28B 137M
Novartis NOVN:VX USD 3.84B 180M
Philips PHIA:NA EUR 3.2B 621M
Roche Holding ROG:VX 8.95B 613M
RWE RWE:GR EUR 3.87B 7.87B
Smith & Nephew PLC SN/:LN 773M 36M
William Demant Holding WDH:DC DKK 2.62B 208M